GlassScriptPhysician profile
Laura Mordi
NPI 1548286826
$1,078.21
in general payments reported to CMS, 2019-2025
16 companies · $95.99 in 2025
The $95.99 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $27.00 · 2021: $106 · 2022: $71.86 · 2023: $234 · 2024: $424 · 2025: $95.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $176.98 | 2021-2024 | |
| Pfizer INC. | $162.07 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $119.80 | 2022-2025 | Rexulti |
| Astellas Pharma US INC | $104.45 | 2019-2025 | Veozah |
| Novo Nordisk INC | $70.88 | 2024-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $67.74 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| E.R. Squibb & Sons, L.L.C. | $63.24 | 2019-2021 | |
| Amgen INC. | $53.91 | 2022-2023 | Repatha, Otezla |
| Tempus Ai, INC | $53.88 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $38.53 | 2024 | Bd Onclarity |
| Lilly USA, LLC | $37.49 | 2020-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $34.86 | 2019-2024 | Airsupra |
| Novartis Pharmaceuticals Corporation | $28.01 | 2024 | |
| Dexcom, INC. | $24.19 | 2024 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $22.80 | 2023 | Dupixent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $19.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Mordi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.